Nrx pharmaceutical's chairman and chief executive officer jonathan javitt to present company business update at h.c. wainwright bioconnect virtual conference

Radnor, pa., jan. 07, 2022 (globe newswire) -- nrx pharmaceuticals (nasdaq: nrxp), a clinical-stage, biopharmaceutical company, today announced its chairman of the board and chief executive officer, prof jonathan javitt, md, mph, will be presenting updates to the company's business at the h.c. wainwright bioconnect virtual conference.
NRXP Ratings Summary
NRXP Quant Ranking